Home Tags TH19P01

Tag: TH19P01

Peptide–drug Conjugate Sudocetaxel Zendusortide Shows Potential as a Single Agent and...

Sudocetaxel zendusortide, also known as TH1902, is as novel, investigational peptide-drug conjugate (PDC) candidate being developed by Canadian biotech Theratechnologies as single agent and in combination with other anticancer therapies. The drug targets tumors that express the sortilin (SORT1) receptor.